Skip to main content
. 2019 Apr 17;13(4):435–440. doi: 10.1049/iet-nbt.2018.5415

Table 3.

Antibacterial activity of antibacterial formulations against MDR‐ESBL E. coli

Antibacterial formulation Conc., µg/ml Inhibition zone (mean ± SD), mm
ceftriaxone (CRO) 10 12.0
ceftriaxone (CRO) 20 13.5
(AgO2 ‐Nps) 10 14.5
(AgO2 ‐Nps) 20 18.0
(CRO + AgO2 ‐Nps) 10 + 10 26.4
(CRO + AgO2 ‐Nps) 20 + 20 32.6